Cite
HARVARD Citation
Kim, D. et al. (2022). Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphoma. Leukemia & lymphoma. 63 (6), pp. 1339-1347. [Online].